---
name: bioavailability_ma_et_al
description: |-
    Oral bioavailability is defined as the rate and extent to which the
    active ingredient or active moiety is absorbed from a drug product and becomes
    available at the site of action.
targets:
    - id: bioavailable
      description: whether it is bioavailable (1) or not (0)
      units:
      type: boolean
      names:
          - noun: oral bioavailability
          - noun: bioavailability
          - adjective: is bioavailable
      uris:
          - http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70913
benchmarks:
    - name: TDC
      link: https://tdcommons.ai/
      split_column: split
identifiers:
    - id: SMILES
      type: SMILES
      description: SMILES
    - id: compound_name
      type: Other
      names:
          - noun: compound name
          - noun: drug name
          - noun: generic drug name
      description: drug name
license: CC BY 4.0
links:
    - url: https://doi.org/10.1016/j.jpba.2008.03.023
      description: corresponding publication
    - url: https://tdcommons.ai/single_pred_tasks/adme/#bioavailability-ma-et-al
      description: data source
num_points: 640
bibtex:
    - |-
      @article{Ma2008,
      doi = {10.1016/j.jpba.2008.03.023},
      url = {https://doi.org/10.1016/j.jpba.2008.03.023},
      year = {2008},
      month = aug,
      publisher = {Elsevier BV},
      volume = {47},
      number = {4-5},
      author = {Chang-Ying Ma and Sheng-Yong Yang and Hui Zhang
      and Ming-Li Xiang and Qi Huang and Yu-Quan Wei},
      title = {Prediction models of human plasma protein binding rate and
      oral bioavailability derived by using GA-CG-SVM method},
      journal = {Journal of Pharmaceutical and Biomedical Analysis}
